Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15398809 | 0.67 | CYP19A1 (0.32) | CYP19A1 | |
| SCHEMBL171853 | 0.64 | HDAC8 (0.47) | CLK4 | |
| SCHEMBL3596326 | 0.62 | CYP2A6 (0.35) | CYP19A1CLK4 | |
| SCHEMBL13801157 | 0.62 | CYP19A1 (0.39) | CYP19A1 | |
| SCHEMBL556950 | 0.62 | PDPK1 (0.54) | CYP19A1 | |
| SCHEMBL2373403 | 0.61 | HDAC8 (0.33) | CLK4 | |
| Hydrochloric Acid SCHEMBL6534749 | 0.61 | HDAC8 (0.44) | CLK4 | |
| SCHEMBL29810143 | 0.61 | HDAC8 (0.44) | CLK4 | |
| SCHEMBL17144230 | 0.61 | HDAC8 (0.44) | CLK4 | |
| SCHEMBL28383937 | 0.61 | HDAC8 (0.44) | CLK4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100305124-A1 | Acylated Aminopyridine and Aminopyridazine Insecticides | BAYER CROPSCIENCE AG (DE) | 2010-12-02 | — | — | US | disclosed |
| EP-2236505-A1 | Acylated aminopyridines and pyridazines as insecticides | Bayer CropScience AG (DE) | 2010-10-06 | — | — | EP | disclosed |
| US-20030162967-A1 | Novel N-guanidinoalkylamides, their preparation, their use, and pharmaceutical preparations comprising them | AVENTIS PHARMA DEUTSCHLAND GMBH | 2003-08-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030162967-A1 | Novel N-guanidinoalkylamides, their preparation, their use, and pharmaceutical preparations comprising them | F7, GUCY1A2, F9 | CYP19A1 1627/4885CLK4 2701/4885 |
| US-20100305124-A1 | Acylated Aminopyridine and Aminopyridazine Insecticides | AAAS, DDT, QDPR | CYP19A1 726/4885CLK4 3547/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.